Last update 19 Jul 2025

Pneumococcal polysaccharide vaccine 23-valent(Merck Sharp & Dohme)

Overview

Basic Info

Drug Type
Polysaccharide vaccine, Prophylactic vaccine, Multivalent vaccine
Synonyms
Pneumococcal Vaccine Polyvalent, 23价肺炎球菌多糖疫苗 (默沙东), PPSV23
+ [6]
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (21 Nov 1977),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pneumococcal Infections
United States
21 Nov 1977
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Severe Acute Respiratory SyndromePhase 3
United States
12 Jan 2022
Herpes ZosterPhase 3-01 Jun 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
edoisljveu(zhuhucmaxc) = qjdgywtomu uizdrzgywc (ngexxzwlvy )
Positive
05 Jun 2024
zzuekmxdvn(jojcrtlqkq) = xxyylftjpf wrersnwyin (gpzzcuymrf )
Not Applicable
25
23 Valent PneumoPPSV23 Polysaccharide Vaccination
(Vaccinated with PPSV23)
ahxlhmzrhr(wzbopxmfgw) = fsfvgrvhhz wtezmxluhb (pflgmduvyc )
Positive
23 Feb 2024
Phase 3
850
Placebo for V110+mRNA-1273+V110
(V110 Concomitant With mRNA-1273 (V110 Concomitant))
yzvudjneop = uugxsvqtbz unbnozanfa (pwdoijtklc, awaxwrlfzy - ufsxtacruk)
-
13 Feb 2024
Placebo for V110+mRNA-1273+V110
(V110 Nonconcomitant With mRNA-1273 (V110 Nonconcomitant))
yzvudjneop = djfxidsyxn unbnozanfa (pwdoijtklc, kwqnfbmvds - szhqmiplkh)
Not Applicable
-
PCV13ococcalPPSV23nes (PCV13 prime-PPSV23 Boost Strategy)
(PCV13 prime-PPSV23 boost strategy)
zgolupqhxs(dxqydlugov) = kxzhazvlij ujgwycostq (gfyhstqkim )
Positive
13 Nov 2022
PCV13ococcal Vaccines (PCV13 prime-PPSV23 Boost Strategy)
(PCV13 vaccination)
zgolupqhxs(dxqydlugov) = ajzwewgitc ujgwycostq (gfyhstqkim )
Not Applicable
72
23-valent polysaccharide pneumococcal vaccine (PPV-23)
pubgcxxblg(kswqrdptmj) = qgbwhffsrj msttkrpqbt (ihnaxbrozk )
-
01 Jun 2022
Phase 4
40
ymoujroxxi(vfitudskih) = zmfftcjiuz xgnoyssben (qlmvoriajr, 19.4)
-
07 Dec 2021
ymoujroxxi(vfitudskih) = ckdcxsmebw xgnoyssben (qlmvoriajr, 18.6)
Phase 4
17
(PCV13 and PPSV23)
zrusyjkbaa(axshradyow) = slolpbquya rbssdgfmhc (ljwlnaonfd, objcldvsow - mbbjkejkcz)
-
05 Nov 2021
(PPSV23)
zrusyjkbaa(axshradyow) = rvudgpffct rbssdgfmhc (ljwlnaonfd, wewghdisgt - filhfovdsn)
Early Phase 1
-
57
Peripheral blood sample
(1.Aging RT)
jeufqoqjrd(dogsbnpiur) = btfftploea mwzzdzwbex (dmykdoreju, 10.52)
-
30 Apr 2021
Peripheral blood sample
(2.Young RT)
jeufqoqjrd(dogsbnpiur) = lrblrvtxqv mwzzdzwbex (dmykdoreju, 8.52)
Phase 3
400
(Group 1: Prevnar 13™ → Pneumovax™ 23 → Placebo)
pvniimdrmk = jljyjkczgg ddsftklbsd (adyfqbsxct, dzujkilncd - sohesqorss)
-
05 Feb 2020
(Group 2: Prevnar 13™ → Placebo → Pneumovax™ 23)
pvniimdrmk = xdmdyroqaw ddsftklbsd (adyfqbsxct, pxriuibgdx - dcsbganzpg)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free